EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force

@article{Evers2009EFNSGO,
  title={EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force},
  author={S. Evers and J. {\'A}fra and A. Frese and P. Goadsby and M. Linde and A. May and P. S{\'a}ndor},
  journal={European Journal of Neurology},
  year={2009},
  volume={16}
}
  • S. Evers, J. Áfra, +4 authors P. Sándor
  • Published 2009
  • Medicine
  • European Journal of Neurology
  • Background:  Migraine is one of the most frequent disabling neurological conditions with a major impact on the patients’ quality of life. 
    457 Citations

    Paper Mentions

    Observational Patient Registry Clinical Trial
    Observational, prospective, descriptive, open study on response predictors and tolerability of Candesartan in patients >18 years with episodic or chronic migraine with prior failure of… Expand
    ConditionsHead Pain, Migraine
    InterventionDrug
    Interventional Clinical Trial
    Chronic migraine (CM) is a prevalent and devastating disorder with limited therapeutic options. This study explored the efficacy of 10 mg/day flunarizine for CM prophylaxis as… Expand
    ConditionsChronic Migraine
    InterventionDrug
    Safety and efficacy of flunarizine in childhood migraine: 11 years’ experience, with emphasis on its effect in hemiplegic migraine
    • 40
    • PDF
    Migraine: New US guidelines for preventive treatment of migraine
    • 7
    The cost of headache disorders in Europe: the Eurolight project
    • 387
    • PDF
    Diagnosis and Treatment of Primary Headache Disorders in Older Adults
    • 6
    Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
    • 11
    Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
    • 13
    Chronic Migraine – Evolution of the Concept and Clinical Implications
    • 7
    • Highly Influenced

    References

    SHOWING 1-10 OF 230 REFERENCES
    Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double‐Blind, Placebo‐Controlled Study
    • P. Winner, D. Lewis, +4 authors On Behalf Of The Rizatriptan Adolescent Study Grou
    • Medicine
    • Headache
    • 2002
    • 137
    Rofecoxib in the Acute Treatment of Migraine: A Randomized Controlled Clinical Trial
    • 31
    Severe Vascular Events in Migraine Patients
    • 139